Preliminary application progresses of ultrasound contrast agents Sonazoid in lymph node metastasis of thyroid cancer
10.13929/j.issn.1672-8475.2024.11.013
- VernacularTitle:超声造影剂Sonazoid(示卓安)用于甲状腺癌淋巴结转移初步进展
- Author:
Danyang HE
1
;
Wei DENG
;
Yingxia ZHANG
Author Information
1. 内蒙古医科大学附属医院超声诊断科,内蒙古 呼和浩特 010050
- Keywords:
thyroid neoplasms;
lymphatic metastasis;
ultrasonography;
contrast media
- From:
Chinese Journal of Interventional Imaging and Therapy
2024;21(11):712-715
- CountryChina
- Language:Chinese
-
Abstract:
Cervical lymph node metastasis(CLNM)is an important risk factor for recurrence of thyroid cancer,and ultrasound is the first imaging method for preoperative assessing status of cervical lymph node.Ultrasound contrast agents can be used to enhance the echo difference between target site and surrounding tissue,reflect microvascular perfusion and improve diagnostic accuracy.As a new ultrasound contrast agent approved for sale in China in recent years,Sonazoid demonstrated good stability and unique ability of vascular late-phase imaging.The physical properties and preliminary application progresses of Sonazoid in CLNM of thyroid cancer were reviewed in this article.
